Glucose -Dependent Insulinotropic Polypeptide (GIP) Contributes Substantially to the Improved Beta -Cell Function during Sitagliptin Treatment in Persons with Type 2 Diabetes

Signe Stensen, Laerke S. Gasbjerg, Mette M. Rosenkilde, Bolette Hartmann, Tina Vilsboll, Jens J. Holst, Mikkel B. Christensen, Filip K. Knop

Original languageEnglish
Publication dateJun 2021
DOIs
Publication statusPublished - Jun 2021

Cite this